Global End-Stage Renal Disease (ESRD) Drugs Sales Market Report 2021

Global End-Stage Renal Disease (ESRD) Drugs Sales Market Report 2021

Table of Contents
1 End-Stage Renal Disease (ESRD) Drugs Market Overview
1.1 End-Stage Renal Disease (ESRD) Drugs Product Scope
1.2 End-Stage Renal Disease (ESRD) Drugs Segment by Type
1.2.1 Global End-Stage Renal Disease (ESRD) Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 Calcium Succinate
1.2.3 Mk-3866
1.2.4 Pacritinib
1.2.5 Sanguinate
1.2.6 Tesidolumab
1.2.7 Others
1.3 End-Stage Renal Disease (ESRD) Drugs Segment by Application
1.3.1 Global End-Stage Renal Disease (ESRD) Drugs Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 ICU
1.3.5 Others
1.4 End-Stage Renal Disease (ESRD) Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global End-Stage Renal Disease (ESRD) Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global End-Stage Renal Disease (ESRD) Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global End-Stage Renal Disease (ESRD) Drugs Price Trends (2016-2027)
2 End-Stage Renal Disease (ESRD) Drugs Estimates and Forecasts by Region
2.1 Global End-Stage Renal Disease (ESRD) Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global End-Stage Renal Disease (ESRD) Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Region (2016-2021)
2.3 Global End-Stage Renal Disease (ESRD) Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global End-Stage Renal Disease (ESRD) Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America End-Stage Renal Disease (ESRD) Drugs Estimates and Projections (2016-2027)
2.4.2 Europe End-Stage Renal Disease (ESRD) Drugs Estimates and Projections (2016-2027)
2.4.3 China End-Stage Renal Disease (ESRD) Drugs Estimates and Projections (2016-2027)
2.4.4 Japan End-Stage Renal Disease (ESRD) Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia End-Stage Renal Disease (ESRD) Drugs Estimates and Projections (2016-2027)
2.4.6 India End-Stage Renal Disease (ESRD) Drugs Estimates and Projections (2016-2027)
3 Global End-Stage Renal Disease (ESRD) Drugs Competition Landscape by Players
3.1 Global Top End-Stage Renal Disease (ESRD) Drugs Players by Sales (2016-2021)
3.2 Global Top End-Stage Renal Disease (ESRD) Drugs Players by Revenue (2016-2021)
3.3 Global End-Stage Renal Disease (ESRD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in End-Stage Renal Disease (ESRD) Drugs as of 2020)
3.4 Global End-Stage Renal Disease (ESRD) Drugs Average Price by Company (2016-2021)
3.5 Manufacturers End-Stage Renal Disease (ESRD) Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global End-Stage Renal Disease (ESRD) Drugs Market Size by Type
4.1 Global End-Stage Renal Disease (ESRD) Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Global End-Stage Renal Disease (ESRD) Drugs Price by Type (2016-2021)
4.2 Global End-Stage Renal Disease (ESRD) Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Global End-Stage Renal Disease (ESRD) Drugs Price Forecast by Type (2022-2027)
5 Global End-Stage Renal Disease (ESRD) Drugs Market Size by Application
5.1 Global End-Stage Renal Disease (ESRD) Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Global End-Stage Renal Disease (ESRD) Drugs Price by Application (2016-2021)
5.2 Global End-Stage Renal Disease (ESRD) Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global End-Stage Renal Disease (ESRD) Drugs Price Forecast by Application (2022-2027)
6 North America End-Stage Renal Disease (ESRD) Drugs Market Facts & Figures
6.1 North America End-Stage Renal Disease (ESRD) Drugs Sales by Company
6.1.1 North America End-Stage Renal Disease (ESRD) Drugs Sales by Company (2016-2021)
6.1.2 North America End-Stage Renal Disease (ESRD) Drugs Revenue by Company (2016-2021)
6.2 North America End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Type
6.2.1 North America End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Type (2016-2021)
6.2.2 North America End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Type (2022-2027)
6.3 North America End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Application
6.3.1 North America End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Application (2016-2021)
6.3.2 North America End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Application (2022-2027)
7 Europe End-Stage Renal Disease (ESRD) Drugs Market Facts & Figures
7.1 Europe End-Stage Renal Disease (ESRD) Drugs Sales by Company
7.1.1 Europe End-Stage Renal Disease (ESRD) Drugs Sales by Company (2016-2021)
7.1.2 Europe End-Stage Renal Disease (ESRD) Drugs Revenue by Company (2016-2021)
7.2 Europe End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Type
7.2.1 Europe End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Type (2016-2021)
7.2.2 Europe End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Type (2022-2027)
7.3 Europe End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Application
7.3.1 Europe 116 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 116 Sales Breakdown by Application (2022-2027)
8 China End-Stage Renal Disease (ESRD) Drugs Market Facts & Figures
8.1 China End-Stage Renal Disease (ESRD) Drugs Sales by Company
8.1.1 China End-Stage Renal Disease (ESRD) Drugs Sales by Company (2016-2021)
8.1.2 China End-Stage Renal Disease (ESRD) Drugs Revenue by Company (2016-2021)
8.2 China End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Type
8.2.1 China End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Type (2016-2021)
8.2.2 China End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Type (2022-2027)
8.3 China End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Application
8.3.1 China 142 Sales Breakdown by Application (2016-2021)
8.3.2 China 142 Sales Breakdown by Application (2022-2027)
9 Japan End-Stage Renal Disease (ESRD) Drugs Market Facts & Figures
9.1 Japan End-Stage Renal Disease (ESRD) Drugs Sales by Company
9.1.1 Japan End-Stage Renal Disease (ESRD) Drugs Sales by Company (2016-2021)
9.1.2 Japan End-Stage Renal Disease (ESRD) Drugs Revenue by Company (2016-2021)
9.2 Japan End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Type
9.2.1 Japan End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Type (2016-2021)
9.2.2 Japan End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Type (2022-2027)
9.3 Japan End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia End-Stage Renal Disease (ESRD) Drugs Market Facts & Figures
10.1 Southeast Asia End-Stage Renal Disease (ESRD) Drugs Sales by Company
10.1.1 Southeast Asia End-Stage Renal Disease (ESRD) Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia End-Stage Renal Disease (ESRD) Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Type
10.2.1 Southeast Asia End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)
11 India End-Stage Renal Disease (ESRD) Drugs Market Facts & Figures
11.1 India End-Stage Renal Disease (ESRD) Drugs Sales by Company
11.1.1 India End-Stage Renal Disease (ESRD) Drugs Sales by Company (2016-2021)
11.1.2 India End-Stage Renal Disease (ESRD) Drugs Revenue by Company (2016-2021)
11.2 India End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Type
11.2.1 India End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Type (2016-2021)
11.2.2 India End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Type (2022-2027)
11.3 India End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Application
11.3.1 India End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Application (2016-2021)
11.3.2 India End-Stage Renal Disease (ESRD) Drugs Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in End-Stage Renal Disease (ESRD) Drugs Business
12.1 CTI BioPharma Corp
12.1.1 CTI BioPharma Corp Corporation Information
12.1.2 CTI BioPharma Corp Business Overview
12.1.3 CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Products Offered
12.1.5 CTI BioPharma Corp Recent Development
12.2 Merck & Co Inc
12.2.1 Merck & Co Inc Corporation Information
12.2.2 Merck & Co Inc Business Overview
12.2.3 Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Products Offered
12.2.5 Merck & Co Inc Recent Development
12.3 Novartis AG
12.3.1 Novartis AG Corporation Information
12.3.2 Novartis AG Business Overview
12.3.3 Novartis AG End-Stage Renal Disease (ESRD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Novartis AG End-Stage Renal Disease (ESRD) Drugs Products Offered
12.3.5 Novartis AG Recent Development
12.4 Prolong Pharmaceuticals LLC
12.4.1 Prolong Pharmaceuticals LLC Corporation Information
12.4.2 Prolong Pharmaceuticals LLC Business Overview
12.4.3 Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Products Offered
12.4.5 Prolong Pharmaceuticals LLC Recent Development
12.5 VESSL Therapeutics Ltd
12.5.1 VESSL Therapeutics Ltd Corporation Information
12.5.2 VESSL Therapeutics Ltd Business Overview
12.5.3 VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Products Offered
12.5.5 VESSL Therapeutics Ltd Recent Development
...
13 End-Stage Renal Disease (ESRD) Drugs Manufacturing Cost Analysis
13.1 End-Stage Renal Disease (ESRD) Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of End-Stage Renal Disease (ESRD) Drugs
13.4 End-Stage Renal Disease (ESRD) Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 End-Stage Renal Disease (ESRD) Drugs Distributors List
14.3 End-Stage Renal Disease (ESRD) Drugs Customers
15 Market Dynamics
15.1 End-Stage Renal Disease (ESRD) Drugs Market Trends
15.2 End-Stage Renal Disease (ESRD) Drugs Drivers
15.3 End-Stage Renal Disease (ESRD) Drugs Market Challenges
15.4 End-Stage Renal Disease (ESRD) Drugs Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global End-Stage Renal Disease (ESRD) Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global End-Stage Renal Disease (ESRD) Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global End-Stage Renal Disease (ESRD) Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs) by Region (2016-2021)
Table 5. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Region (2016-2021)
Table 6. Global End-Stage Renal Disease (ESRD) Drugs Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global End-Stage Renal Disease (ESRD) Drugs Revenue Share by Region (2016-2021)
Table 8. Global End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share Forecast by Region (2022-2027)
Table 10. Global End-Stage Renal Disease (ESRD) Drugs Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global End-Stage Renal Disease (ESRD) Drugs Revenue Share Forecast by Region (2022-2027)
Table 12. Global End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global End-Stage Renal Disease (ESRD) Drugs Sales Share by Company (2016-2021)
Table 14. Global End-Stage Renal Disease (ESRD) Drugs Revenue (US$ Million) by Company (2016-2021)
Table 15. Global End-Stage Renal Disease (ESRD) Drugs Revenue Share by Company (2016-2021)
Table 16. Global End-Stage Renal Disease (ESRD) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in End-Stage Renal Disease (ESRD) Drugs as of 2020)
Table 17. Global End-Stage Renal Disease (ESRD) Drugs Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers End-Stage Renal Disease (ESRD) Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers End-Stage Renal Disease (ESRD) Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs) by Type (2016-2021)
Table 22. Global End-Stage Renal Disease (ESRD) Drugs Sales Share by Type (2016-2021)
Table 23. Global End-Stage Renal Disease (ESRD) Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global End-Stage Renal Disease (ESRD) Drugs Price (USD/Pcs) by Type (2016-2021)
Table 25. Global End-Stage Renal Disease (ESRD) Drugs Sales Share by Type (2022-2027)
Table 26. Global End-Stage Renal Disease (ESRD) Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global End-Stage Renal Disease (ESRD) Drugs Revenue Share by Type (2022-2027)
Table 28. Global End-Stage Renal Disease (ESRD) Drugs Price (USD/Pcs) by Type (2022-2027)
Table 29. Global End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs) by Application (2016-2021)
Table 30. Global End-Stage Renal Disease (ESRD) Drugs Sales Share by Application (2016-2021)
Table 31. Global End-Stage Renal Disease (ESRD) Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global End-Stage Renal Disease (ESRD) Drugs Price (USD/Pcs) by Application (2016-2021)
Table 33. Global End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs) by Application (2022-2027)
Table 34. Global End-Stage Renal Disease (ESRD) Drugs Sales Share by Application (2022-2027)
Table 35. Global End-Stage Renal Disease (ESRD) Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global End-Stage Renal Disease (ESRD) Drugs Revenue Share by Application (2022-2027)
Table 37. Global End-Stage Renal Disease (ESRD) Drugs Price (USD/Pcs) by Application (2022-2027)
Table 38. North America End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs) by Company (2016-2021)
Table 39. North America End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Company (2016-2021)
Table 40. North America End-Stage Renal Disease (ESRD) Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Company (2016-2021)
Table 42. North America End-Stage Renal Disease (ESRD) Drugs Sales by Type (2016-2021) & (K Pcs)
Table 43. North America End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type (2016-2021)
Table 44. North America End-Stage Renal Disease (ESRD) Drugs Sales by Type (2022-2027) & (K Pcs)
Table 45. North America End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type (2022-2027)
Table 46. North America End-Stage Renal Disease (ESRD) Drugs Sales by Application (2016-2021) & (K Pcs)
Table 47. North America End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application (2016-2021)
Table 48. North America End-Stage Renal Disease (ESRD) Drugs Sales by Application (2022-2027) & (K Pcs)
Table 49. North America End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application (2022-2027)
Table 50. Europe End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs) by Company (2016-2021)
Table 51. Europe End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Company (2016-2021)
Table 52. Europe End-Stage Renal Disease (ESRD) Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Company (2016-2021)
Table 54. Europe End-Stage Renal Disease (ESRD) Drugs Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type (2016-2021)
Table 56. Europe End-Stage Renal Disease (ESRD) Drugs Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type (2022-2027)
Table 58. Europe End-Stage Renal Disease (ESRD) Drugs Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application (2016-2021)
Table 60. Europe End-Stage Renal Disease (ESRD) Drugs Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application (2022-2027)
Table 62. China End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs) by Company (2016-2021)
Table 63. China End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Company (2016-2021)
Table 64. China End-Stage Renal Disease (ESRD) Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 65. China End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Company (2016-2021)
Table 66. China End-Stage Renal Disease (ESRD) Drugs Sales by Type (2016-2021) & (K Pcs)
Table 67. China End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type (2016-2021)
Table 68. China End-Stage Renal Disease (ESRD) Drugs Sales by Type (2022-2027) & (K Pcs)
Table 69. China End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type (2022-2027)
Table 70. China End-Stage Renal Disease (ESRD) Drugs Sales by Application (2016-2021) & (K Pcs)
Table 71. China End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application (2016-2021)
Table 72. China End-Stage Renal Disease (ESRD) Drugs Sales by Application (2022-2027) & (K Pcs)
Table 73. China End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application (2022-2027)
Table 74. Japan End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs) by Company (2016-2021)
Table 75. Japan End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Company (2016-2021)
Table 76. Japan End-Stage Renal Disease (ESRD) Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Company (2016-2021)
Table 78. Japan End-Stage Renal Disease (ESRD) Drugs Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type (2016-2021)
Table 80. Japan End-Stage Renal Disease (ESRD) Drugs Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type (2022-2027)
Table 82. Japan End-Stage Renal Disease (ESRD) Drugs Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application (2016-2021)
Table 84. Japan End-Stage Renal Disease (ESRD) Drugs Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia End-Stage Renal Disease (ESRD) Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia End-Stage Renal Disease (ESRD) Drugs Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia End-Stage Renal Disease (ESRD) Drugs Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia End-Stage Renal Disease (ESRD) Drugs Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia End-Stage Renal Disease (ESRD) Drugs Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application (2022-2027)
Table 98. India End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs) by Company (2016-2021)
Table 99. India End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Company (2016-2021)
Table 100. India End-Stage Renal Disease (ESRD) Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 101. India End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Company (2016-2021)
Table 102. India End-Stage Renal Disease (ESRD) Drugs Sales by Type (2016-2021) & (K Pcs)
Table 103. India End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type (2016-2021)
Table 104. India End-Stage Renal Disease (ESRD) Drugs Sales by Type (2022-2027) & (K Pcs)
Table 105. India End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type (2022-2027)
Table 106. India End-Stage Renal Disease (ESRD) Drugs Sales by Application (2016-2021) & (K Pcs)
Table 107. India End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application (2016-2021)
Table 108. India End-Stage Renal Disease (ESRD) Drugs Sales by Application (2022-2027) & (K Pcs)
Table 109. India End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application (2022-2027)
Table 110. CTI BioPharma Corp Corporation Information
Table 111. CTI BioPharma Corp Description and Business Overview
Table 112. CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Product
Table 114. CTI BioPharma Corp Recent Development
Table 115. Merck & Co Inc Corporation Information
Table 116. Merck & Co Inc Description and Business Overview
Table 117. Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Product
Table 119. Merck & Co Inc Recent Development
Table 120. Novartis AG Corporation Information
Table 121. Novartis AG Description and Business Overview
Table 122. Novartis AG End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Novartis AG End-Stage Renal Disease (ESRD) Drugs Product
Table 124. Novartis AG Recent Development
Table 125. Prolong Pharmaceuticals LLC Corporation Information
Table 126. Prolong Pharmaceuticals LLC Description and Business Overview
Table 127. Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Product
Table 129. Prolong Pharmaceuticals LLC Recent Development
Table 130. VESSL Therapeutics Ltd Corporation Information
Table 131. VESSL Therapeutics Ltd Description and Business Overview
Table 132. VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Product
Table 134. VESSL Therapeutics Ltd Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. End-Stage Renal Disease (ESRD) Drugs Distributors List
Table 138. End-Stage Renal Disease (ESRD) Drugs Customers List
Table 139. End-Stage Renal Disease (ESRD) Drugs Market Trends
Table 140. End-Stage Renal Disease (ESRD) Drugs Market Drivers
Table 141. End-Stage Renal Disease (ESRD) Drugs Market Challenges
Table 142. End-Stage Renal Disease (ESRD) Drugs Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. End-Stage Renal Disease (ESRD) Drugs Product Picture
Figure 2. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type in 2021 & 2027
Figure 3. Calcium Succinate Product Picture
Figure 4. Mk-3866 Product Picture
Figure 5. Pacritinib Product Picture
Figure 6. Sanguinate Product Picture
Figure 7. Tesidolumab Product Picture
Figure 8. Others Product Picture
Figure 9. Global End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application in 2021 & 2027
Figure 10. Hospital Examples
Figure 11. Clinic Examples
Figure 12. ICU Examples
Figure 13. Others Examples
Figure 14. Global End-Stage Renal Disease (ESRD) Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global End-Stage Renal Disease (ESRD) Drugs Sales Growth Rate (2016-2027) & (US$ Million)
Figure 16. Global End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs) Growth Rate (2016-2027)
Figure 17. Global End-Stage Renal Disease (ESRD) Drugs Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 18. Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Region: 2016 VS 2021
Figure 19. Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Region: 2021 VS 2027
Figure 20. North America End-Stage Renal Disease (ESRD) Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. North America End-Stage Renal Disease (ESRD) Drugs Sales (K Pcs) Growth Rate (2016-2027)
Figure 22. Europe End-Stage Renal Disease (ESRD) Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Europe End-Stage Renal Disease (ESRD) Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 24. China End-Stage Renal Disease (ESRD) Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. China End-Stage Renal Disease (ESRD) Drugs Sales (Million USD) and Growth Rate (2016-2027)
Figure 26. Japan End-Stage Renal Disease (ESRD) Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. Japan End-Stage Renal Disease (ESRD) Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Southeast Asia End-Stage Renal Disease (ESRD) Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. Southeast Asia End-Stage Renal Disease (ESRD) Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 30. India End-Stage Renal Disease (ESRD) Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 31. India End-Stage Renal Disease (ESRD) Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 32. Global 5 Largest End-Stage Renal Disease (ESRD) Drugs Players Market Share by Revenue in End-Stage Renal Disease (ESRD) Drugs: 2016 & 2020
Figure 33. End-Stage Renal Disease (ESRD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 34. Global End-Stage Renal Disease (ESRD) Drugs Revenue Share by Type (2016-2021)
Figure 35. Global End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 36. Global End-Stage Renal Disease (ESRD) Drugs Revenue Share by Application (2016-2021)
Figure 37. Global End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 38. North America End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type in 2020
Figure 39. North America End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application in 2020
Figure 40. Europe End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type in 2020
Figure 41. Europe End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application in 2020
Figure 42. China End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type in 2020
Figure 43. China End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application in 2020
Figure 44. Japan End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type in 2020
Figure 45. Japan End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application in 2020
Figure 46. Southeast Asia End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type in 2020
Figure 47. Southeast Asia End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application in 2020
Figure 48. India End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Type in 2020
Figure 49. India End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Application in 2020
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of End-Stage Renal Disease (ESRD) Drugs
Figure 52. Manufacturing Process Analysis of End-Stage Renal Disease (ESRD) Drugs
Figure 53. End-Stage Renal Disease (ESRD) Drugs Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs